AKR1C3 and neoplasm: Only 3 (37%) of the radiosensitive tumor samples had intermediate levels of AKR1C3 but 5 (63%) showed a low or undetectable level (+/−) of AKR1C3 expression (Fig. 5A–B and Fig. S4 in File S1).